tiprankstipranks
Trending News
More News >
Lincoln Pharmaceuticals Ltd (IN:LINCOLN)
:LINCOLN
India Market

Lincoln Pharmaceuticals Ltd (LINCOLN) Financial Statements

Compare
2 Followers

Lincoln Pharmaceuticals Ltd Financial Overview

Lincoln Pharmaceuticals Ltd's market cap is currently ₹9.76B. The company's EPS TTM is ₹9.977; its P/E ratio is 12.20; and it has a dividend yield of 0.37%. Lincoln Pharmaceuticals Ltd is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 6.23B₹ 5.81B₹ 5.05B₹ 4.68B₹ 4.15B
Gross Profit₹ 3.32B₹ 2.97B₹ 2.59B₹ 2.46B₹ 2.13B
Operating Income₹ 885.94M₹ 832.22M₹ 779.91M₹ 1.65B₹ 720.15M
EBITDA₹ 1.24B₹ 1.34B₹ 1.12B₹ 1.05B₹ 928.43M
Net Income₹ 823.46M₹ 933.05M₹ 728.99M₹ 693.55M₹ 622.50M
Balance Sheet
Cash & Short-Term Investments₹ 1.96B₹ 1.52B₹ 1.14B₹ 1.15B₹ 945.06M
Total Assets₹ 7.97B₹ 7.00B₹ 5.87B₹ 5.34B₹ 4.52B
Total Debt₹ 0.00₹ 10.67M₹ 19.97M₹ 20.44M₹ 5.20M
Net Debt₹ -134.14M₹ -46.80M₹ -30.55M₹ -48.90M₹ -109.19M
Total Liabilities₹ 1.25B₹ 1.07B₹ 849.46M₹ 1.01B₹ 859.67M
Stockholders' Equity₹ 6.72B₹ 5.93B₹ 5.02B₹ 4.33B₹ 3.66B
Cash Flow
Free Cash Flow₹ 737.71M₹ 237.41M₹ 249.80M₹ 306.07M₹ 605.19M
Operating Cash Flow₹ 930.15M₹ 632.17M₹ 392.62M₹ 761.32M₹ 692.70M
Investing Cash Flow₹ -789.47M₹ -573.42M₹ -366.43M₹ -780.80M₹ -642.27M
Financing Cash Flow₹ -64.02M₹ -51.80M₹ -45.01M₹ -25.56M₹ -57.45M
Currency in INR

Lincoln Pharmaceuticals Ltd Earnings and Revenue History

Lincoln Pharmaceuticals Ltd Debt to Assets

Lincoln Pharmaceuticals Ltd Cash Flow

Lincoln Pharmaceuticals Ltd Forecast EPS vs Actual EPS